In 2023, PharmaEssentia completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, PharmaEssentia has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore PharmaEssentia’s data sources below and access millions more through our Disclosure Search .
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
In 2023, the total operational greenhouse gas (GHG) emissions of PharmaEssentia amounted to 3,598.36 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of PharmaEssentia decreased by 0.23%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
In 2023, the total Scope 1 emissions of PharmaEssentia were 692.39 metric tons of COâ‚‚ equivalent (tCOâ‚‚e). a
Since 2019, PharmaEssentia's Scope 1 emissions have decreased by 2.1%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), PharmaEssentia's Scope 1 emissions increased by 21.57%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
In 2023, PharmaEssentia reported Scope 2 greenhouse gas (GHG) emissions of 2,905.97 tCOâ‚‚e without specifying the calculation method. a
Since 2019, PharmaEssentia's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that PharmaEssentia 's emissions have plateaued with no significant change in its energy consumption footprint. a
Compared to the previous year (2022), PharmaEssentia's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that PharmaEssentia 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2023, PharmaEssentia reported its Scope 2 emissions using an unspecified methodology. a
In 2023, PharmaEssentia reported 775.04 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2023 disclosure of PharmaEssentia includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
In 2023, PharmaEssentia reported total Scope 3 emissions of 775.04 metric tons of COâ‚‚ equivalent (tCOâ‚‚e). a
Since 2019, PharmaEssentia's Scope 3 emissions have remained relatively stable, indicating that PharmaEssentia 's emissions have plateaued with no significant change in its value chain footprint. a
Compared to the previous year (2022), PharmaEssentia's Scope 3 emissions increased by 17.82%, suggesting that the company faced challenges in reducing emissions across its value chain. a
In 2023, PharmaEssentia reported a total carbon footprint of 4,373.4 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 2.55% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to PharmaEssentia's total carbon footprint was Scope 2 emissions, accounting for 66.45% of the company's total carbon footprint, followed by Scope 3 emissions at 17.72%. a